Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$68.49
$68.47
$21.65
$73.02
$4.62B0.452.07 million shs74 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$11.25
-8.1%
$13.97
$5.65
$17.16
$2.41B0.974.68 million shs12.01 million shs
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
$16.47
$16.09
$5.94
$17.55
$3.37B1.993.22 million shs523,503 shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$12.78
-1.6%
$14.44
$12.53
$30.41
$2.17B0.974.85 million shs6.19 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
0.00%0.00%0.00%0.00%0.00%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-1.96%-0.12%-18.28%+38.11%+3.29%
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
0.00%0.00%0.00%0.00%0.00%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
+1.48%-2.51%-9.32%-34.32%-49.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
4.0796 of 5 stars
4.32.00.00.02.44.21.9
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
N/AN/AN/AN/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.8024 of 5 stars
4.21.00.00.01.62.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.64
Moderate Buy$14.8531.97% Upside
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
N/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.35
Hold$18.7346.58% Upside

Current Analyst Ratings

Latest TDOC, ONEM, HIMS, and GBT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/29/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$17.00 ➝ $15.00
4/26/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$26.00 ➝ $21.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$25.00 ➝ $18.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$15.00 ➝ $14.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$16.00 ➝ $15.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$21.00 ➝ $16.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$25.00 ➝ $20.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $25.00
4/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/16/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$17.00 ➝ $15.00
(Data available from 5/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
$194.75M23.73N/AN/A$3.05 per share22.46
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$872M2.76N/AN/A$1.61 per share6.99
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
$1.05B3.22N/AN/A$9.06 per share1.82
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.60B0.83$0.81 per share15.78$13.50 per share0.95

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
-$303.09M-$5.01N/AN/AN/A-137.30%-170.37%-39.24%N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$23.55M-$0.11N/A45.00N/A-2.70%-7.21%-5.81%5/6/2024 (Confirmed)
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
-$254.64M-$2.01N/AN/AN/A-38.05%-24.58%-15.62%N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$220.37M-$1.41N/AN/AN/A-8.90%-10.13%-5.37%7/23/2024 (Estimated)

Latest TDOC, ONEM, HIMS, and GBT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0160N/A-$0.0160N/AN/AN/A  
4/25/2024Q1 2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.47-$0.49-$0.02-$0.49$637.31 million$646.13 million    
2/26/2024Q4 2023
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.02$0.01+$0.03$0.01$245.84 million$246.60 million      
2/20/2024Q4 2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.22-$0.17+$0.05-$0.17$670.79 million$660.50 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.92
6.88
6.17
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
3.00
2.74
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
0.20
2.09
2.06
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.67
3.82
3.47

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
78.20%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%

Insider Ownership

CompanyInsider Ownership
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
4.90%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
31.63%
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
4.40%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.95%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Global Blood Therapeutics, Inc. stock logo
GBT
Global Blood Therapeutics
45767.48 million64.17 millionOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,046214.25 million146.48 millionOptionable
1Life Healthcare, Inc. stock logo
ONEM
1Life Healthcare
3,090204.35 million195.36 millionNot Optionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,600169.59 million167.98 millionOptionable

TDOC, ONEM, HIMS, and GBT Headlines

SourceHeadline
Insider Sale at Teladoc Health Inc (TDOC): President of Enterprise Growth Sells SharesInsider Sale at Teladoc Health Inc (TDOC): President of Enterprise Growth Sells Shares
finance.yahoo.com - May 4 at 12:00 AM
Teladoc Health, Inc. (NYSE:TDOC) COO Sells $73,513.17 in StockTeladoc Health, Inc. (NYSE:TDOC) COO Sells $73,513.17 in Stock
insidertrades.com - May 3 at 7:31 AM
TDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost MoneyTDOC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Teladoc Health, Inc. Shareholders Who Lost Money
accesswire.com - May 3 at 7:20 AM
Teladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters Sells 5,793 SharesTeladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters Sells 5,793 Shares
marketbeat.com - May 2 at 7:32 PM
Teladoc: Even UnitedHealth Is Turning Its Back On TelehealthTeladoc: Even UnitedHealth Is Turning Its Back On Telehealth
seekingalpha.com - May 2 at 4:00 PM
Levi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOCLevi & Korsinsky Reminds Teladoc Investors of the Ongoing Investigation into Potential Violations of Securities Laws - TDOC
accesswire.com - May 2 at 7:20 AM
Stock Market Crash Warning: Dont Get Caught Holding These 3 Cathie Wood StocksStock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
investorplace.com - May 2 at 6:00 AM
Teladoc Health, Inc. Forecasted to Post FY2024 Earnings of ($1.00) Per Share (NYSE:TDOC)Teladoc Health, Inc. Forecasted to Post FY2024 Earnings of ($1.00) Per Share (NYSE:TDOC)
americanbankingnews.com - May 2 at 2:04 AM
Teladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by TornadoesTeladoc Health Is Providing Free Virtual Health Care Services to Oklahoma Residents Impacted by Tornadoes
finance.yahoo.com - May 1 at 7:21 PM
Teladoc Health, Inc. (NYSE:TDOC) Expected to Post FY2024 Earnings of ($1.00) Per ShareTeladoc Health, Inc. (NYSE:TDOC) Expected to Post FY2024 Earnings of ($1.00) Per Share
marketbeat.com - May 1 at 8:36 AM
An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TDOC Losses.An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your TDOC Losses.
accesswire.com - May 1 at 7:25 AM
Teladoc Health (TDOC) Q1 Loss Widens on Decline in VisitsTeladoc Health (TDOC) Q1 Loss Widens on Decline in Visits
zacks.com - April 30 at 1:41 PM
Teladoc Health, Inc. (NYSE:TDOC) Q1 2024 Earnings Call TranscriptTeladoc Health, Inc. (NYSE:TDOC) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 30 at 1:17 PM
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC), R1 RCM (RCM) and Gilead Sciences (GILD)
markets.businessinsider.com - April 30 at 8:16 AM
Teladoc Health (NYSE:TDOC) Price Target Cut to $15.00 by Analysts at Wells Fargo & CompanyTeladoc Health (NYSE:TDOC) Price Target Cut to $15.00 by Analysts at Wells Fargo & Company
americanbankingnews.com - April 30 at 6:20 AM
Wells Fargo & Company Cuts Teladoc Health (NYSE:TDOC) Price Target to $15.00Wells Fargo & Company Cuts Teladoc Health (NYSE:TDOC) Price Target to $15.00
marketbeat.com - April 29 at 3:09 PM
Evercore ISI Lowers Teladoc Health (NYSE:TDOC) Price Target to $14.00Evercore ISI Lowers Teladoc Health (NYSE:TDOC) Price Target to $14.00
americanbankingnews.com - April 28 at 6:32 AM
Needham & Company LLC Reiterates "Hold" Rating for Teladoc Health (NYSE:TDOC)Needham & Company LLC Reiterates "Hold" Rating for Teladoc Health (NYSE:TDOC)
americanbankingnews.com - April 28 at 6:32 AM
Stifel Nicolaus Lowers Teladoc Health (NYSE:TDOC) Price Target to $16.00Stifel Nicolaus Lowers Teladoc Health (NYSE:TDOC) Price Target to $16.00
americanbankingnews.com - April 28 at 6:32 AM
TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00TD Cowen Lowers Teladoc Health (NYSE:TDOC) Price Target to $15.00
americanbankingnews.com - April 28 at 6:32 AM
Barclays Lowers Teladoc Health (NYSE:TDOC) Price Target to $20.00Barclays Lowers Teladoc Health (NYSE:TDOC) Price Target to $20.00
americanbankingnews.com - April 28 at 6:32 AM
Teladoc Health (NYSE:TDOC) Price Target Cut to $25.00Teladoc Health (NYSE:TDOC) Price Target Cut to $25.00
americanbankingnews.com - April 28 at 6:32 AM
Royal Bank of Canada Lowers Teladoc Health (NYSE:TDOC) Price Target to $18.00Royal Bank of Canada Lowers Teladoc Health (NYSE:TDOC) Price Target to $18.00
americanbankingnews.com - April 28 at 5:36 AM
Teladoc Health (NYSE:TDOC) PT Lowered to $21.00Teladoc Health (NYSE:TDOC) PT Lowered to $21.00
americanbankingnews.com - April 28 at 5:36 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Global Blood Therapeutics logo

Global Blood Therapeutics

NASDAQ:GBT
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, the company is developing its lead product candidate inclacumab, novel human monoclonal antibody, which is in Phase III a clinical trial to reduce the incidence of painful vaso-occlusive crises, and resulting hospital admissions; and GBT601, a hemoglobin polymerization inhibitor that is in Phase I development. It has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD and beta thalassemia; and Sanofi S.A. to two early-stage research programs in SCD. Global Blood Therapeutics, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.
Hims & Hers Health logo

Hims & Hers Health

NYSE:HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
1Life Healthcare logo

1Life Healthcare

NASDAQ:ONEM
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.
Teladoc Health logo

Teladoc Health

NYSE:TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.